The GLP-1 tracker that monitors your body composition, supports microdosing, correlates symptoms to your drug cycle, and generates a doctor report. For every drug in the class.
You're in. We'll notify you at launch.
No spam. Just one message when Levare is ready.Zero spam · local data only · never shared
We analyzed thousands of negative reviews of competing apps. These are the three gaps nobody has solved.
In SURMOUNT-1 trials, 25% of weight lost was lean mass. No app tracks the fat/muscle ratio or warns you when you're losing too much.
Many patients split their dose to reduce nausea — a practice with solid pharmacokinetic backing. No competitor supports this workflow.
No competitor generates a structured report for your appointment. Patients bring screenshots or describe months of therapy from memory.
Built on real gaps. Every feature addresses a documented pain point from competitor reviews.
Log your body fat % at every weigh-in. The app calculates fat vs lean mass and alerts you if muscle loss exceeds safe thresholds.
Select the fraction injected (25%, 50%...) and the app manages the remaining dose with the right timing.
The app cross-references your symptom logs with injections to show which day of your cycle side effects tend to peak.
Structured document generated locally: injections, weight, body composition, symptoms, exercise, nutrition.
Your weight loss compared week by week against the clinical trial for your drug (SURMOUNT-1, STEP, SCALE).
A 0-10 slider on every log. Your historical average shows how effectively the drug is suppressing appetite over time.
Overlay on your weight chart to distinguish luteal phase water retention from real fat loss.
Notifications show only "Levare — reminder". Your drug name never appears on your lock screen.
Every GLP-1 molecule has a different curve. Tirzepatide drops 68% between day 1 and day 7. Semaglutide only 48%. This explains why your symptoms appear on specific days.
Pharmacokinetic curve, titolazione, reminder e benchmark si adattano automaticamente al tuo farmaco.
After 2025 funding rounds, some competitors raised prices and raised privacy concerns. Levare is built differently: your data is never transmitted to Levare or any third party, under any circumstance.
We'll notify you at launch. No spam, just one message when the app is ready.
Zero spam · privacy by design · English